Drug Eluting Stent Clinical Trial
— AIFSIDDESNCT number | NCT00973375 |
Other study ID # | LHQ09-003 |
Secondary ID | |
Status | Recruiting |
Phase | N/A |
First received | September 8, 2009 |
Last updated | September 8, 2009 |
Start date | May 2009 |
Verified date | September 2009 |
Source | Liuhuaqiao Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | China: Ethics Committee |
Study type | Observational |
The purpose of this study is to investigate if there is any different follow-up results by angiography and IVUS between two different drug-eluting stents after implanted simultaneously in same individuals.
Status | Recruiting |
Enrollment | 30 |
Est. completion date | |
Est. primary completion date | |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years to 75 Years |
Eligibility |
Inclusion Criteria: - These patients who received two kinds of drug-eluting stent (Endeavor and Excel) im simultaneously. Exclusion Criteria: - Dual anti-platelet therapy less than 12 months. |
Observational Model: Case Control, Time Perspective: Cross-Sectional
Country | Name | City | State |
---|---|---|---|
China | Liuhuaqiao Hospital | Guangzhou | Guangdong |
Lead Sponsor | Collaborator |
---|---|
Liuhuaqiao Hospital |
China,
Lee CH, Zhang J, Kailasam A, Tai BC, Ye F, Low AF, Hou X, Hay ET, Teo SG, Lim YT, Chen S, Tan HC. An intravascular ultrasound study of Cypher, Taxus, and endeavor stents on relation between neointimal proliferation and residual plaque burden. J Interv Cardiol. 2008 Dec;21(6):519-27. doi: 10.1111/j.1540-8183.2008.00397.x. Epub 2008 Oct 21. — View Citation
Miyazawa A, Ako J, Hongo Y, Hur SH, Tsujino I, Courtney BK, Hassan AH, Kandzari DE, Honda Y, Fitzgerald PJ; ENDEAVOR III Investigators. Comparison of vascular response to zotarolimus-eluting stent versus sirolimus-eluting stent: intravascular ultrasound results from ENDEAVOR III. Am Heart J. 2008 Jan;155(1):108-13. Epub 2007 Sep 14. — View Citation
Waseda K, Miyazawa A, Ako J, Hasegawa T, Tsujino I, Sakurai R, Yock PG, Honda Y, Kandzari DE, Leon MB, Fitzgerald PJ; ENDEAVOR IV Trial Investigators. Intravascular ultrasound results from the ENDEAVOR IV trial: randomized comparison between zotarolimus- and paclitaxel-eluting stents in patients with coronary artery disease. JACC Cardiovasc Interv. 2009 Aug;2(8):779-84. doi: 10.1016/j.jcin.2009.05.015. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Segment and instent restenosis measured by coronary angiography and IVUS. | at 12 months after implantation | No | |
Secondary | Uncovered and malposition of stent. | at 12 months after implantation. | Yes |
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT05477940 -
Study on Absorbable Zinc Alloy Drug Eluting Coronary Stent System
|
N/A | |
Not yet recruiting |
NCT04518826 -
A Comparison Between FFR Guided and CAG Guided Treatment Using DEB in ISR of DES
|
||
Recruiting |
NCT03287167 -
Comparison One vs Six Months of Dual Antiplatelet Therapy After Implanted Firehawk TM Stent in High Bleeding Risk Patients With Coronary Artery Disease
|
Phase 4 | |
Completed |
NCT03859674 -
Firehorus Rapamycin Target Eluting Vertebral Artery Stent System in Clinical Application
|
N/A | |
Completed |
NCT01239914 -
CathOlic Medical Center percutAneous Coronary inTervention Registry (COACT)
|
||
Completed |
NCT03622203 -
Outcome of CHAllenging lesioNs and Patients Treated With Polymer Free Drug-CoatEd Stent
|
||
Recruiting |
NCT05658250 -
CREATE Trial, Prospective, Observational Study
|
||
Completed |
NCT03312296 -
Definite Stent Thrombosis in Comatose Out of Hospital Cardiac Arrest Survivors
|